tiprankstipranks
Advertisement
Advertisement

AU:CU6 Stock Latest News

Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
Company AnnouncementsClarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
18d ago
CU6
Clarity Pharmaceuticals Director Sells Shares to Cover Tax from Option Exercise
PremiumCompany Announcements
Clarity Pharmaceuticals Director Sells Shares to Cover Tax from Option Exercise
2M ago
CU6
Clarity Expands U.S. Manufacturing Network for Prostate Cancer Imaging Agent
PremiumCompany Announcements
Clarity Expands U.S. Manufacturing Network for Prostate Cancer Imaging Agent
2M ago
CU6
Citigroup Ceases to Be Substantial Holder in Clarity Pharmaceuticals
PremiumCompany Announcements
Citigroup Ceases to Be Substantial Holder in Clarity Pharmaceuticals
2M ago
CU6
Clarity Pharmaceuticals Director Colin Biggin Steps Down but Retains Significant Equity Stake
PremiumCompany Announcements
Clarity Pharmaceuticals Director Colin Biggin Steps Down but Retains Significant Equity Stake
2M ago
CU6
Clarity Pharmaceuticals Reshapes Board as It Moves Toward Commercial Launch
PremiumCompany AnnouncementsClarity Pharmaceuticals Reshapes Board as It Moves Toward Commercial Launch
2M ago
CU6
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Clarity Pharmaceuticals Issues New Unquoted Options Under Employee Incentive Scheme
2M ago
CU6
Clarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
Premium
Company Announcements
Clarity Pharmaceuticals Issues New Shares on Option Exercise in Routine Capital Move
2M ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
PremiumCompany Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for Small Tranche of New Shares
2M ago
CU6
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
PremiumCompany Announcements
Clarity’s PSMA Imaging Agent Shows Superior Performance in Key Prostate Cancer Study
2M ago
CU6
Clarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
PremiumCompany Announcements
Clarity Secures Major U.S. Copper-64 Supply Deal with Theragenics
3M ago
CU6
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
PremiumCompany Announcements
Clarity’s 64Cu-SAR-bisPSMA tops standard imaging in prostate cancer trial
3M ago
CU6
Clarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
PremiumCompany AnnouncementsClarity Pharmaceuticals Issues New Shares via Option Exercises, Confirms Regulatory Compliance
3M ago
CU6
Clarity Pharmaceuticals Seeks ASX Quotation for New Share Issuance
Premium
Company Announcements
Clarity Pharmaceuticals Seeks ASX Quotation for New Share Issuance
3M ago
CU6
Clarity hits Phase III AMPLIFY enrollment goal for prostate cancer imaging agent
Premium
Company Announcements
Clarity hits Phase III AMPLIFY enrollment goal for prostate cancer imaging agent
3M ago
CU6
Clarity Pharmaceuticals Issues Additional Unquoted Employee Options
PremiumCompany Announcements
Clarity Pharmaceuticals Issues Additional Unquoted Employee Options
3M ago
CU6
Clarity Pharmaceuticals Releases 2026 Interim Report Detailing Pipeline and Financial Progress
PremiumCompany Announcements
Clarity Pharmaceuticals Releases 2026 Interim Report Detailing Pipeline and Financial Progress
4M ago
CU6
Clarity Pharmaceuticals Posts Wider Half-Year Loss but Lifts Net Tangible Assets
PremiumCompany Announcements
Clarity Pharmaceuticals Posts Wider Half-Year Loss but Lifts Net Tangible Assets
4M ago
CU6
Clarity flags more prostate cancer patients with no detectable disease in SECuRE trial
PremiumCompany Announcements
Clarity flags more prostate cancer patients with no detectable disease in SECuRE trial
4M ago
CU6
Clarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
PremiumCompany AnnouncementsClarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
4M ago
CU6
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
Premium
Company Announcements
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
5M ago
CU6
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
Premium
Company Announcements
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
5M ago
CU6

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >